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Tissue-resident memory T (Trm) cells represent a
populationofmemoryCD8+Tcells that canact asfirst
responders to local infection. The mechanisms regu-
lating the formationandmaintenanceof intestinal Trm
cells remain elusive. Here we showed that transform-
ing growth factor-b (TGF-b) controlled both stages of
gut Trm cell differentiation through different mecha-
nisms. During the formation phase of Trm cells,
TGF-b signaling inhibited the migration of effector
CD8+ T cells from the spleen to the gut by dampening
the expression of integrin a4b7. During the mainte-
nance phase, TGF-b was required for the retention
of intestinal Trm cells at least in part through the
induction of integrins aEb7 and a1, as well as CD69.
Thus, the cytokine acts to control cytotoxic T cell
differentiation in lymphoid and peripheral organs.
INTRODUCTION
CD8+ memory T cells have long been divided into two circulating
populations termed central memory T (Tcm) and effector mem-
ory T (Tem) cells. Tcm cells migrate between the secondary
lymphoid organs and blood and represent a long-lived popula-
tion of memory cells with a superior proliferative capacity upon
pathogen re-encounter. Tem cells traffic through spleen, blood
and peripheral tissues, and maintain immediate effector poten-
tial (Masopust et al., 2001; Sallusto et al., 1999). There is accu-
mulating evidence to support the existence of a third population
of CD8+ memory T cells that never returns to the circulation
(Mueller et al., 2012; Sheridan and Lefranc¸ois, 2011). These
tissue-resident memory (Trm) cells are a self-sustaining popula-
tion within nonlymphoid tissues and are phenotypically distinct
from Tem cells. Trm cells have been identified in a variety of tis-
sues including the skin, dorsal root ganglia, brain, salivary
glands, vagina, stomach, kidney, pancreas, heart, and gut
(Casey et al., 2012; Gebhardt et al., 2009, 2011; Hawke et al.,
1998; Hofmann and Pircher, 2011; Jiang et al., 2012; Masopust
et al., 2010; Tang and Rosenthal, 2010; Wakim et al., 2010). In
many tissues, Trm cells are required for optimal protection
against subsequent local infection (Gebhardt et al., 2009; Jiang
et al., 2012; Mackay et al., 2012; Schenkel et al., 2013; Wakim
et al., 2008).Intestinal Trm cells are relatively well characterized. During
both local and systemic infections, CD8+ effector T cells develop
gut-homing capacity through the upregulation of the integrin
a4b7 and the chemokine receptor CCR9 (Johansson-Lindbom
et al., 2003; Kim et al., 1997; Masopust et al., 2001, 2010;
Mora et al., 2003; Stagg et al., 2002). Integrin a4b7 binds to
the mucosal addressin cell adhesion molecule-1 (MAdCAM-1),
which is expressed by a subset of vascular endothelial cells in
the intestinal lamina propria (Berlin et al., 1993, 1995). Antibody
blocking of this interaction prevents the migration of effector
T cells to the gut (Bargatze et al., 1995; Hamann et al., 1994).
However, the signals that control the expression of integrin
a4b7 on effector T cells remain largely unidentified. Interestingly,
during acute viral infection, there is a narrowwindow (day 4.5 to 7
after infection) for splenic effector CD8+ T cells to express a
sufficient amount of integrin a4b7 to mediate migration to the
intestine (Masopust et al., 2010). Whether the intestinal traf-
ficking capacity of CD8+ T cells is under similar control during
chronic infection remains largely unexplored.
Upon arrival in the intestinal tissues including both the lamina
propria (LP) and intraepithelial lymphocyte (IEL) compartments,
CD8+ T cells quickly acquire novel surface phenotypes such as
the downregulation of integrin a4b7 and upregulation of CD103
(integrin aE) and the lectin CD69 (Casey et al., 2012; Masopust
et al., 2010). Integrin aEb7 binds to E-cadherin, which is consti-
tutively expressed by intestinal epithelial cells. This interaction
might mediate the tethering of IELs to the intestinal epithelium
(Cepek et al., 1994). Trm cells that lack CD103 expression are
defective in the long-term maintenance in the intestinal IEL
compartment (Casey et al., 2012; Scho¨n et al., 1999). CD69 in-
hibits the expression of S1P1 (Shiow et al., 2006), which medi-
ates the egress of T cells from lymphoid organs (Cyster and
Schwab, 2012). In addition, integrin a1 (the a subunit of very
late antigen-1, VLA-1) is highly expressed on gut IEL cells
(Choy et al., 1990) and might mediate the retention of CD8+
T cells in the mucosal tissues (Meharra et al., 2000; Roberts
et al., 1999; Sandoval et al., 2013). Thus the expression of
CD103, CD69, and integrin a1 together may contribute to the
retention of Trm cells within the gut.
It has been known for more than two decades that transform-
ing growth factor-b (TGF-b) signaling greatly enhances the
expression of CD103 on activated T cells in vitro (Kilshaw and
Murant, 1990). In vivo, TGF-b promotes CD103 expression on
CD8+ effector T cells in the gut in a graft versus host disease
model (El-Asady et al., 2005). Recently, it was shown that
TGF-b is required for the differentiation of CD103+CD69+ CD8+Immunity 39, 687–696, October 17, 2013 ª2013 Elsevier Inc. 687
Figure 1. Response in the Spleen of TGF-bRII-Deficient CD8+ T Cells
after Acute and Chronic LCMV Infection
Naive P14 T cells were purified from control (CD45.1+) and TGF-bRII-deficient
(CD45.1+CD90.1+)mice, mixed at a 1:1 ratio, and 104 cells transferred into sex-
matched B6 recipients followed by LCMV Armstrong or clone 13 infection. The
expression of TGF-bRII on P14 T cells is shown in (A) and (B). Representative
FACS plots of P14 T cells are shown in (C). The ratio of control versus TGF-
bRII-deficient P14 cells is shown in (D) (combined data from four independent
experiments). Each symbol in (B) and (D) represents an individual recipient
mouse. *p < 0.05 (Student t test). Data in (B) and (D) are represented asmean ±
SEM. See also Figure S1.
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TGF-b Controls Migration to and Residence in GutT cell within the IEL compartment at the effector phase of an
immune response to acute lymphocytic choriomeningitis virus
(LCMV) infection (Casey et al., 2012). Therefore, it is generally
believed that TGF-b signaling is essential for the retention of
intestinal Trm cells through the induction of CD103 expression.
However, because T cell-specific deletion of TGF-b receptor
early in development (Tgfbr2f/f CD4-cre) leads to an early onset
lethal autoimmune disease (Li et al., 2006; Marie et al., 2006),
all previous work employed a transgenic mouse model carrying
a dominant-negative form of TGF-b receptor II (dnTGF-bRII) in
T cells (Gorelik and Flavell, 2000). Presumably due to the limita-
tions of dnTGF-bRII mice (Ishigame et al., 2013; Sanjabi and Fla-
vell, 2010), there is no direct evidence to support the role of
TGF-b signaling in the long-term maintenance of the intestinal
Trm compartment during the memory phase of an immune
response. Beside the induction of CD103 expression, there is
no evidence to support other functions that TGF-b signaling
might have in the Trm cells.
Recently, we introduced a different model of T cell-specific
conditional deletion of TGF-bRII employing Cre driven by the
distal promoter of the gene encoding the kinase Lck (dLck-cre)
in which deletion begins after T cell positive selection and con-688 Immunity 39, 687–696, October 17, 2013 ª2013 Elsevier Inc.tinues slowly in the periphery (Zhang and Bevan, 2012). In adult
Tgfbr2f/f dLck-cre mice, although the vast majority of T cells lack
TGF-bRII expression, no signs of autoimmunity are observed. To
study the function of TGF-b signaling to T cells in the formation
and maintenance of intestinal Trm compartment during viral
infection, we generated Tgfbr2f/f dLck-cre (hereafter referred
to as Tgfbr2/) P14 TCR transgenic mice, that carry CD8+
T cells specific for the Db-GP33–41 LCMV epitope. Here, we
report that virus specific CD8+ T cells express a markedly
increased amount of TGF-bRII during chronic compared to acute
LCMV infection. During acute LCMV Armstrong infection, TGF-b
signaling is essential for the maintenance of intestinal Trm
compartment at least in part through the induction of CD103,
CD69, and integrins b7 and a1. To our surprise, during chronic
LCMV clone 13 infection, the Tgfbr2/ Trm population is appar-
ently normal in spite of the similar defects in the expression of
CD103, CD69, and integrins b7 and a1 in the absence of
TGF-b signaling. To solve this obvious discrepancy, we demon-
strate that during chronic LCMV infection, the expression of
integrin a4b7 and the a4b7-dependent trafficking of effector
CD8+ T cells from the secondary lymphoid organs to the gut
are substantially enhanced in the absence of TGF-b signaling.
Thus, during the prolonged infection with LCMV Clone 13, effec-
tors able to traffic to the gut are continually generated. Therefore,
TGF-b plays location and stage-specific roles in the formation
and maintenance of the intestinal Trm compartment. In the sec-
ondary lymphoid organs during the formation phase, TGF-b
inhibits effector CD8+ T cells from migrating to the gut, whereas
in the gut during the maintenance phase, TGF-b signaling
promotes CD8+ T cell residency.
RESULTS
Enhanced TGF-bRII Expression on CD8+ T Cells during
Chronic LCMV Infection
To investigate the role of TGF-b signaling to CD8+ T cells during
acute and chronic viral infection, we adoptively transferred equal
numbers of congenically marked control and Tgfbr2/ naive
P14 T cells into wild-type (WT) mice followed by LCMV
Armstrong or Clone 13 infection. Interestingly, the surface
expression of TGF-bRII on control P14 cells was substantially
increased in chronically infected mice compared to that of
acutely infected mice (Figures 1A and 1B; see Figure S1A avail-
able online). The enhanced expression of TGF-bRII in Clone 13
infected mice was a long-lasting effect (Figure 1B). The lack of
staining of TGF-bRII on Tgfbr2/ P14 T cells confirmed the effi-
cient deletion mediated by dLck-cre. Consistent with a previous
report (Tinoco et al., 2009), the phosphorylation of Smad 2 and
Smad 3 downstream of TGF-b signaling was greatly increased
in the P14 T cells isolated from LCMV Clone 13 infected mice
compared to that from LCMV Armstrong infected mice (Fig-
ure S1A). Together, these results indicated that antigen-specific
CD8+ T cells received a stronger TGF-b signal during chronic
LCMV infection at least in part due to enhanced surface expres-
sion of TGF-bRII.
Slightly Reduced Expansion of Tgfbr2–/– P14 T Cells
Previous reports using dnTGF-bRII transgenic mice sug-
gested that with decreased TGF-b signaling, the expansion of
Figure 2. Defective Maintenance of TGF-bRII-Deficient CD8+ T Cells in the Gut following Acute, but Not Chronic LCMV Infection
Similar experimental setup as in Figure 1. Data from LCMV Armstrong infected mice are shown in (A–C), and from LCMV clone 13 infected mice in (D–F). At the
indicated time after infection, lymphocytes were purified from the lamina propria and IEL compartment of the recipient mice. Representative FACS plots are
shown in (A) and (D). The ratio of control versus TGF-bRII-deficient P14 cells is shown in (B) and (E) (combined data from four independent experiments). The
percentage of P14 T cells in CD8b+ IEL cells is shown in (C) and (F) (combined data from four independent experiments). Each symbol in (B) and (E) represents an
individual recipient mouse. Data in (B), (C), (E), and (F) are represented as mean ± SEM. See also Figure S2.
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TGF-b Controls Migration to and Residence in Gutantigen-specific CD8+ T cells was significantly increased in
response to both acute and chronic infections due to reduced
apoptosis of effector T cells (Sanjabi et al., 2009; Tinoco et al.,
2009). During chronic LCMV infection, dnTGF-bRII CD8+
T cells appeared less functionally exhausted, exhibiting
increased cytokine production and cytotoxicity and decreased
expression of PD-1 (Tinoco et al., 2009). In sharp contrast, in
our system based on conditional deletion of the TGF-b receptor,
CD8+ T cell expansion in the spleen was slightly but consistently
decreased in the absence of TGF-b signaling (Figure 1C and 1D;
Figure S1B). P14 expansion was robust for both control and
Tgfbr2/ populations in these experiments: 38.2% ± 3.1%
(Armstrong, n = 13) and 27.8% ± 2.7% (Clone 13, n = 11) of total
CD8+ T cells were donor P14 T cells at day 8 after infection. IFN-g
and IL-2 production and the expression of PD-1 were compara-
ble between control and Tgfbr2/ P14 T cells following acute
and chronic viral infection (data not shown; Figure S1C). In one
(Tinoco et al., 2009) but not other previous reports (Boettler
et al., 2012; Garidou et al., 2012), blocking TGF-b signaling
resulted in accelerated clearance of LCMV clone 13 infection.
In our system, viral antigens were present in tissues for a pro-
longed period following LCMV clone 13 infection (Figure S1D).
Thus, TGF-b signaling slightly promoted the expansion of
CD8+ T cells during LCMV infection while it was not critically
involved in the functional exhaustion of CD8+ T cells during
persistent viral infection.Defective Maintenance of Tgfbr2–/– P14 Cells in the Gut
following Acute but Not Chronic Infection
To investigate the function of TGF-b signaling in the formation
and maintenance of intestinal Trm cells, an equal number of
naive P14 T cells from congenically marked control and
Tgfbr2/ mice were cotransferred into WT mice followed by
LCMV Armstrong or Clone 13 infection. At different time points
following the infection, donor P14 T cells in the lamina propria
and IEL compartment of the small intestine were examined. At
the peak of the response following acute LCMV Armstrong infec-
tion, comparable numbers of control and Tgfbr2/ P14 T cells
accumulated in the lamina propria and IEL compartment (Figures
2A, 2B, and 2C). However, shortly after LCMV Armstrong clear-
ance (day 14 after infection), the number of Tgfbr2/ P14 T cells
declined in the intestinal tissues. At day 35 to 36 after infection,
the number of Tgfbr2/ cells were reduced more than 45-fold
compared to the cotransferred control P14 cells in the intestinal
IEL compartment. A similar, but less dramatic, decrease of the
Tgfbr2/ cell population in the lamina propria was also
observed (Figures 2A and 2B). Notably, at the same time and
in the same mice, there were no severe defects in the number
of Tgfbr2/ cells in the spleen (Figures 1C and 1D; Figure S1B).
In sharp contrast to the picture with acute LCMV infection, no
significant (p > 0.2) decreasewas observed for the Tgfbr2/P14
T cell population in the intestinal lamina propria and IEL compart-
ment following LCMV Clone 13 infection (Figures 2D–2F).Immunity 39, 687–696, October 17, 2013 ª2013 Elsevier Inc. 689
Figure 3. TGF-bRII-Deficient Cells in the
Gut Exhibit Reduced Expression of Markers
Associated with Retention
Similar experimental setup as in Figure 1. On day 8
(A), 14 (B), and 24 (C) after LCMV infection,
lymphocytes were purified from the lamina propria
and IEL compartment of the recipient mice. The
expression of integrin b7, CD103, and CD69 on the
P14 T cells were determined by flow cytometry.
Data are representative of four independent
experiments. See also Figure S3.
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TGF-b Controls Migration to and Residence in GutImportantly, the percentage of control and Tgfbr2/ P14 T cells
in the CD8+ IEL compartment during chronic infection was com-
parable to that of control P14 cells during acute infection (Figures
2C and 2F). In addition, the percentage of total CD8+ T cells in the
IEL compartment remained elevated for a prolonged period
following chronic LCMV infection (Figure S2). Therefore, TGF-b
unresponsive CD8+ T cells exhibited severe defects in the main-
tenance of intestinal Trm cells following acute but not chronic
LCMV infection.
Defective Retention of TGF-bRII-Deficient T Cells in the
Gut
To elucidate the underlying mechanisms leading to the dramat-
ically different outcomes of the gut Trm cell population following
acute versus chronic LCMV infection, the phenotype of P14
T cells isolated from the small intestine was characterized.
Compared to dnTGF-bRII T cells from the gut that express
reduced but readily detectable amounts of CD103 (Casey
et al., 2012; El-Asady et al., 2005), CD103 expression on
Tgfbr2/ P14 T cells was absent. The expression of CD69
was slightly but consistently reduced on Tgfbr2/ P14 T cells
(Figure 3). Furthermore, the expression of integrin b7 was sub-
stantially decreased on Tgfbr2/ cells from the IEL compart-
ment at day 14 and 24 after infection (Figures 3B and 3C).
Consistent with a previous report (Casey et al., 2012), the690 Immunity 39, 687–696, October 17, 2013 ª2013 Elsevier Inc.expression of CD103 on control P14
T cells was reduced from clone 13
compared with Armstrong infected
mice. Moreover, defective expression of
integrin a1 was observed on Tgfbr2/
P14 T cells in the IEL compartment (Fig-
ure S3). Thus, the defective expression
of integrins aEb7, a1, and CD69 likely
result in the severely impaired retention
of Tgfbr2/ CD8+ T cells in the gut
following acute LCMV infection. How-
ever, similar defects were exhibited by
the intestinal Tgfbr2/ P14 cells from
chronically infected mice (Figure 3; Fig-
ure S3). Therefore, the surface molecules
associated with the retention of Trm cells
were similarly defective on Tgfbr2/ P14
cells from both acutely and chronically
infected animals.
To directly test the retention of
Tgfbr2/ T cells in the gut, we modified
the protocol used to purify IEL (see Experimental Procedures).
In short, a more gentle isolation step was added before the stan-
dard vigorous step. Thus, the IEL were divided into a loosely
attached (from the gentle step) and a tightly attached (from the
vigorous step) population. Compared to control P14 T cells,
Tgfbr2/ P14 cells were enriched in the loose IEL population
following both acute and chronic LCMV infection (Figure 4).
Considering the facts that control and Tgfbr2/ T cells exhibited
comparable apoptosis (Figure S4A) and proliferation (Fig-
ure S4B), we concluded that defective retention of Tgfbr2/
T cells was observed following both acute and chronic LCMV
infection. These results left open the question: Why was the
Tgfbr2/ CD8+ Trm cell population in the gut maintained nor-
mally during chronic LCMV infection?
Increased Expression of Integrin a4b7 on Tgfbr2–/– P14
Cells in the Spleen and Peripheral Blood
To answer the above question, we examined the P14 T cells from
the secondary lymphoid organs, which were the major source of
intestinal Trm cells. Interestingly, we found that the expression of
integrin b7 and a4b7 was increased on Tgfbr2/ T cells from the
spleen (Figure 5A) and peripheral blood (Figure 5B). The effect
was more dramatic during LCMV clone 13 infection compared
to Armstrong infection (Figures 5A and 5B). To address the pos-
sibility that naive TGF-bRII-deficient P14 T cells were already
Figure 4. Defective Retention of TGF-bRII-Deficient T Cells in the
gut IEL
Similar experimental setup as in Figure 1. At day 8 and 12 after LCMV Arm
infection and day 8 and 15 after LCMV Cl13 infection, IEL cells were purified
following a two-step protocol. The ratio of control versus TGF-bRII-deficient
P14 T cells in the tight and loose IEL populations is shown. Each pair of
symbols represents an individual recipient mouse. Combined data from three
independent experiments are shown. See also Figure S4.
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TGF-b Controls Migration to and Residence in Gutprogrammed to express higher level of a4b7 than control P14
cells upon activation, we directly tested the effect of TGF-b
signaling on WT P14 T cells in vitro. As shown in Figure S5,
TGF-b dramatically inhibited the expression of a4b7 on activated
WT P14 T cells in vitro. We concluded that TGF-b signaling
downregulated the expression of integrin a4b7 on effector
CD8+ T cells.
Integrin a4b7 is required for the trafficking of activated T cells
to the gut (Bargatze et al., 1995; Hamann et al., 1994). Thus, to
explain the different outcomes in the maintenance of the gut
Trm cells following acute versus chronic LCMV infection, we
reasoned as follows: During acute LCMV infection, virus was
cleared around day 8 following infection. Under these condi-
tions, both control and Tgfbr2/ CD8+ T cells quickly lost the
expression of integrin a4b7 and the capacity to migrate to the
gut. However, during chronic LCMV infection, virus persisted
for a longer time. TGF-b signaling significantly inhibited the
expression of integrin a4b7 giving Tgfbr2/ CD8+ T cells a
greatly enhanced capacity to migrate to the gut. In the intestinal
tissues, TGF-b was required for the expression of integrin aEb7
and the optimal upregulation of CD69 and integrin a1 so that
TGF-b unresponsive T cells were poorly retainedwithin the intes-
tine. Therefore, during acute infection, without continuous
recruits from secondary lymphoid organs, Tgfbr2/ T cells
quickly disappeared from the intestinal compartment. On the
other hand, during chronic infection, enhanced continuedmigra-
tion of CD8+ T cells to the gut counterbalanced the defective
maintenance of gut Trm cells in the absence of TGF-b signaling.
Increased Migration of Tgfbr2–/– CD8+ T Cells to the Gut
following LCMV Clone 13 Infection
To directly test the above hypothesis, we examined the gut-
homing capacity of control and Tgfbr2/ P14 T cells followingacute and chronic infection. At day 9 after infection, pooled lym-
phocytes from the spleen and lymph nodes, containing a mix of
control and Tgfbr2/ P14 effector T cells, were transferred into
naive mice. At the time of transfer, dramatically enhanced
expression of integrin a4b7 was observed only for the Tgfbr2/
T cells from LCMV clone 13 infected mice (Figure 6A). Nineteen
hours after the cell transfer, donor control and Tgfbr2/ P14
T cells in different tissues were quantified. Control and
Tgfbr2/ T cells from both LCMV Armstrong and Clone 13
infected mice showed comparable homing capacity to the
spleen (Figure 6B). Control and Tgfbr2/ T cells from acute
LCMV infectedmice exhibited aminimal but comparable homing
capacity to the intestinal IEL compartment. In sharp contrast,
Tgfbr2/ CD8+ T cells from chronic LCMV clone 13 infected
mice exhibited greatly enhanced homing capacity to the intesti-
nal IEL compartment (Figure 6B). Similar results were observed
when P14 T cells were transferred into infection-matched recip-
ient mice (Figure S6).
Next, we tested whether the increased expression of integrin
a4b7 resulted in the enhanced gut-homing capacity and mainte-
nance of normal numbers of Tgfbr2/ T cells from chronic
LCMV infectedmice. To this end, naive P14 T cells from congeni-
cally marked control and Tgfbr2/ mice were mixed and trans-
ferred into WT recipients followed by LCMV clone 13 infection
(Figure S7A). Starting at day 10 after infection, integrin a4 block-
ing antibody or control antibody was administrated every other
day. As shown in Figure 7A, anti-integrin a4 antibody efficiently
blocked the surface staining of integrin a4b7. Anti-integrin a4
antibody inhibits the migration of lymphocytes to the mucosal
tissues (Bargatze et al., 1995; Hamann et al., 1994). If our hypoth-
esis were correct, blocking integrin a4 would lead to the defec-
tive maintenance of Tgfbr2/ T cells in the intestine of LCMV
clone 13 infected mice. Indeed, we observed that the Tgfbr2/
T cell population from the IEL compartment was significantly
decreased in anti-integrin a4 antibody, but not control immuno-
globulin (Ig)-treated animals (Figures 7B and 7C). Notably, anti-
integrin a4 antibody treatment had minimal effects on splenic
T cells (Figure 7C). To rule out the involvement of other integrins
containing the a4 subunit, such as a4b1, we directly tested the
effect of anti-a4b7 blocking antibody. Indeed, preincubation
with a4b7 blocking antibody, but not control Ig, completely abol-
ished the migration capacity of P14 T cells to the gut following
LCMV clone 13 infection (Figures S7B and S7C). Furthermore,
in contrast to the expression pattern of b7, the expression of
integrin b1 was comparable between control and Tgfbr2/
T cells following both acute and chronic LCMV infection (data
not shown). Taken together, we concluded that the increased
expression of integrin a4b7 led to the enhanced migration of
Tgfbr2/ T cells to the gut. Therefore, during chronic LCMV
infection, Tgfbr2/ P14 T cells exhibited enhanced and pro-
longed gut-homing capacity that compensated for the defective
maintenance of the gut Trm cell population in the absence of
TGF-b signaling.
Decreased Tgfbr2–/– Trm Population in the IEL
Compartment after Clearance of Chronic LCMV
Infection
Following LCMV clone 13 infection, WT mice control and elimi-
nate virus in most tissues around 2 months after infectionImmunity 39, 687–696, October 17, 2013 ª2013 Elsevier Inc. 691
Figure 5. Increased Expression of Integrin
a4b7 on TGF-bRII-Deficient CD8+ T Cells in
the Spleen and Peripheral Blood
Similar experimental setup as in Figure 1. On day
8 and 20 after infection, the expression of
integrin a4b7 and b7 by P14 T cells in the spleen
(A) and peripheral blood (B) was examined. Each
pair of symbols in (B) represents an individual
recipient mouse. Red symbols represent the
mean ± SEM of 14–15 mice. Data are represen-
tative of five independent experiments. See also
Figure S5.
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TGF-b Controls Migration to and Residence in Gut(Lauterbach et al., 2007; Sevilla et al., 2000; Wherry et al., 2003).
To further validate our hypothesis, we examined the IEL
compartment after the clearance of LCMV clone 13 infection.
Elimination of the virus reduced the amounts of viral antigen
and the population of activated CD8+ T cells that was the major
CD8+ T cell population with efficient gut-homing capacity. If our
hypothesis were correct, after the clearance of chronic viral
infection, Tgfbr2/ P14 T cells would decline in the intestinal
IEL compartment similar to the situation after acute viral infec-
tion. Indeed, we found that Tgfbr2/ P14 T cells were signifi-
cantly reduced compared to control cells in the IEL compartment
at 71 days and further reduced at day 105 after infection with
LCMV clone 13 (Figure S8).
DISCUSSION
Our results have revealed two distinct functions of TGF-b
signaling during the formation and maintenance of the intestinal
Trm cell population during systemic viral infection. In secondary
lymphoid organs, TGF-b signaling to T cells inhibits the upregu-
lation of integrin a4b7 and thus the intestinal homing capacity of
effector CD8+ T cells. In the gut, TGF-b signaling is critical for the
maintenance of Trm cells through the induction of integrins aEb7,
a1, and CD69.
The TGF-b-mediated suppression of a4b7 expression and gut
homing was most apparent after chronic infection with LCMV
clone 13. During acute LCMV Armstrong infection, the enhanced
migration of Tgfbr2/ P14 cells to the gut was not substantial
but still present. Tgfbr2/ P14 cells expressed slightly but
consistently higher level of integrin a4b7 during LCMVArmstrong
infection. At an early time point (day 8) following LCMV
Armstrong infection, the ratio of control/Tgfbr2/ P14 T cells
was significantly lower for the IEL compartment compared to692 Immunity 39, 687–696, October 17, 2013 ª2013 Elsevier Inc.that of the spleen (control/Tgfbr2/ =
2.42 ± 0.27 for spleen; 1.21 ± 0.10 for
IEL). Therefore, TGF-b unresponsive P14
T cells had an enhanced ability to traffic
to the gut IEL compartment during both
acute and chronic LCMV infection. How-
ever, after acute LCMV Armstrong
infection, responding T cells lost the gut-
homing capacity shortly after clearance
of the virus, which limited the role of
TGF-b signaling to a narrow window of
active infection. Only after chronic infec-tion did TGF-b play a major and extended role during the forma-
tion of intestinal Trm cells.
TGF-b signaling was also essential for the maintenance of in-
testinal Trm cells. Although TGF-b is generally accepted as a key
cytokine to induce the Trm cell phenotype and promote Trm cell
retention, previous studies focused on the effector, but not
memory phase of an immune response (Casey et al., 2012; El-
Asady et al., 2005). There is no evidence in the literature to
show that lacking or diminishing TGF-b responsiveness leads
to the loss of Trm cells in the memory phase of an immune
response. Here we showed that the molecules involved in Trm
cell retention, such as integrins aEb7, a1, and CD69, were
dramatically reduced and the long-term maintenance of Trm
cells was severely defective in the absence of TGF-b signaling.
As a caveat, it should be noted that the effects of TGF-b signaling
on the expression of integrin b7 might not be direct because in
CD103 deficient mice, the expression of integrin b7 on the gut
IEL lymphocytes was also significantly reduced (Scho¨n et al.,
1999). CD103-deficient P14 T cells exhibit similar but less dra-
matic defects to those exhibited by TGF-b unresponsive P14
T cells (Casey et al., 2012; Scho¨n et al., 1999). Thus, the defective
induction of CD103 alone cannot fully explain the defects in
TGF-b unresponsive resident T cells. The expression of integrin
a1 might contribute to the retention of effector T cells in the
mucosal tissues (Meharra et al., 2000; Roberts et al., 1999; San-
doval et al., 2013). In addition, CD69 inhibits the function of S1P1
(Cyster and Schwab, 2012), which mediates T cell egress from
the lymphoid organs. Therefore, diminished expression of integ-
rins aEb7, a1, and CD69 together might explain the defective
maintenance of TGF-b unresponsive T cells in the gut. Although
more comprehensive analysis is needed to evaluate the homeo-
stasis of TGF-bRII-deficient Trm cells, no apparent defects
in proliferation and apoptosis were observed. Interestingly,
Figure 6. Dramatically Increased Migration
of TGF-bRII-Deficient CD8+ T Cells to the
Gut following LCMV Clone 13 Infection
Similar experimental setup as in Figure 1. On day 9
after infection, 2 3 107 pooled lymphocytes from
spleen and lymph nodes were transferred into
each naive B6 mouse. Nineteen hours later,
recipient mice were sacrificed and the number of
transferred P14 T cells from different tissues was
determined by flow cytometry and cell counting.
(A) The expression of integrin a4b7 and b7 on the
donor P14 T cells before secondary transfer.
(B) The number of recovered P14 cells from the
spleen and IEL compartment. Each pair of sym-
bols represents an individual recipient mouse.
Data are representative of two independent
experiments. See also Figure S6.
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TGF-b Controls Migration to and Residence in GutTGF-bRII-deficient Trm cells were consistently enriched in the
loosely attached IEL population following both acute and chronic
LCMV infection. Together, these data suggest that promoting
retention is the main function of TGF-b signaling in gut Trm cells.
The short life span (3–5 days) of epithelial cells along the small
intestine villi is accompanied by the constant division of progen-
itor cells in the crypts, moving of newly generated epithelial cells
toward the tips of villi, and shedding of the epithelial cells into the
lumen from the tips (Clevers and Batlle, 2013). The retention of
Trm cells in such a dynamic microenvironment is critical to main-
tain the cell population. Our data suggest that the downstream
targets of TGF-b signaling cooperatively mediate the retention
of gut Trm cells.
It has been reported previously that CD8+ T cells carrying a
dominant-negative TGF-bRII transgene exhibit enhanced
expansion during both acute and chronic infections thought to
be due to increased survival (Sanjabi et al., 2009; Tinoco
et al., 2009). In contrast, we consistently observed a slightly
reduced accumulation of TGF-bRII-deficient CD8+ T cells in
response to a variety of pathogens. There are several possibil-
ities that might account for the opposite outcomes of two
different models for suppression of TGF-b signaling. First, the
dnTGF-bRII transgene is driven by the CD4 promoter (Gorelik
and Flavell, 2000) that is activated at the double-positive (DP)
thymocyte stage of T cell development. Distal Lck-cre is acti-
vated after thymocyte positive selection (Hale et al., 2010;
Zhang et al., 2005). Whether interfering with TGF-b signaling
during DP thymocyte development has a long lasting effect
on mature naive T cell expansion remains unknown. Second,
the dnTGF-bRII transgene is of human origin. Direct transfer
of CD8+ T cells carrying the transgene into WT recipient mice
results in the rapid rejection of the donor cells (Sanjabi and
Flavell, 2010). This might be the main reason why in previous re-
ports utilizing dnTGF-bRII mice, only the effector, but not theImmunity 39, 687–696,memory phase of an immune response,
was studied. Transferring dnTGF-bRII
T cells into CD11c-dnTGF-bRII trans-
genic mice overcomes the problem of
rapid rejection of the donor cells (Sanjabi
and Flavell, 2010), but such recipient
mice contain altered populations of den-dritic cells and NK cells (Laouar et al., 2005; Laouar et al., 2008),
which might affect the CD8+ T cell response. Third, the results
from direct infection of dnTGF-bRII T cell transgenic mice
have a potential caveat. Although dnTGF-bRII T cell transgenic
mice remain healthy for 3–4 months (Gorelik and Flavell, 2000),
the asymptomatic young adult mice may harbor a proinflamma-
tory environment with an unexpected impact on the CD8+ T cell
response. Indeed, recent studies have questioned some con-
clusions based on the data obtained from dnTGF-bRII mice
following chronic LCMV infection (Boettler et al., 2012; Garidou
et al., 2012). Furthermore, a recent publication has documented
functions of the dnTGF-bRII transgene that are independent of
endogenous TGF-bRII signaling, which are responsible for the
enhanced expansion of effector CD8+ T cells and the develop-
ment of transformed memory T cells (Ishigame et al., 2013). In
contrast, in our system, a small number of control and TGF-
bRII-deficient naive P14 T cells were cotransferred into WT
recipient mice followed by LCMV infection so that the function
of TGF-b signaling to CD8+ T cells could be examined under
more physiological conditions. It is also to be noted that the
inhibition of TGF-b signaling by the dnTGF-bRII transgene is
not complete (Gorelik and Flavell, 2000). Thus it is that a signif-
icant number of dnTGF-bRII-expressing CD8+ T cells differen-
tiate into CD103+ cells within the intestinal IEL compartment
(Casey et al., 2012; El-Asady et al., 2005). On the contrary, in
our experiments, TGF-bRII-deficient CD8+ T cells completely
lost the ability to upregulate CD103 expression within the intes-
tinal epithelium.
It has been reported that during chronic infection, intestinal
Trm CD8+ T cells exhibit a decreased ability to upregulate
Trm signature molecules including CD103 and CD69 (Casey
et al., 2012). It has been proposed that persistent antigen
stimulation inhibits the acquisition of Trm signatures in the
peripheral tissues except for the brain (Casey et al., 2012),October 17, 2013 ª2013 Elsevier Inc. 693
Figure 7. Blocking Integrin a4 Results in Defective Maintenance of
TGF-bRII-Deficient CD8+ T Cells in the Gut following Chronic
LCMV Infection
Naive P14 T cells were purified from control (CD45.1+CD45.2+) and TGF-bRII-
deficient (CD45.1+) mice, mixed at a 1:1 ratio, and 104 cells transferred into
sex-matched B6 recipients followed by LCMV clone 13 infection. Starting at
day 10 after infection, 400 mg anti-integrin a4 antibody (clone PS/2) or control
Ig were injected intraperitoneally every other day (Figure S7A). Recipients were
examined at day 18 after infection. The expression of integrin a4b7 on splenic
P14 T cells is shown in (A). Representative FACS profiles of the P14 T cells in
the IEL compartment are shown in (B).
(C) The ratio of control versus Tgfbr2/ P14 T cells in spleen and IEL is shown.
Each symbol in (C) represents an individual mouse. *p < 0.05 (Student’s t test).
Data in (C) are represented as mean ± SEM. See also Figures S7 and S8.
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TGF-b Controls Migration to and Residence in Gutwhere antigen stimulation is required for CD103 induction
(Wakim et al., 2010). Our results suggest another possible ex-
planation. Compared to the narrow window for responding
CD8+ T cells to migrate to the gut during an acute infection,
there is a prolonged period of migration to the gut during
chronic infection. Therefore, the CD103 cells observed in the
intestinal IEL compartment during LCMV clone 13 infection
might represent recent arrivals from the secondary lymphoid
organs. The prolonged period of migration to the gut might
also explain the interesting phenomenon that total CD8+
T cells persist at a higher level in the IEL compartment
from chronically infected mice compared to that from acutely
infected mice.
Together, our data demonstrate that TGF-b signaling inhibits
the migration of effector CD8+ T cells from the secondary
lymphoid organs to the intestine by controlling the expression
of integrin a4b7. In the intestinal tissues, TGF-b signaling is
required for the long-term maintenance of Trm cells at least in
part through the induction of integrins aEb7, a1, and CD69.
The mechanisms underlying the tissue and stage-specific func-
tion of TGF-b signaling warrant future investigation, which might
represent another example of context-dependent outcomes of
TGF-b signaling (Massague´, 2012).694 Immunity 39, 687–696, October 17, 2013 ª2013 Elsevier Inc.EXPERIMENTAL PROCEDURES
Mice and Viruses
Tgfbr2f/f dLck-cre mice were as described (Zhang and Bevan, 2012). C57BL/6
(stock no. 000664) mice were obtained from The Jackson Laboratory and a
colony of DbGP33–41 TCR transgenic (P14) mice was maintained at our
specific pathogen-free animal facilities at the University of Washington
(Seattle, WA). All recipient mice were used at 6 to 12 weeks of age. All
experiments were done in accordance with the University of Washington
Institutional Animal Care and Use Committee guidelines. Mice were infected
intraperitoneally with 2 3 105 pfu LCMV Armstrong or intravenously with 2 3
106 pfu LCMV clone 13. Viruses were grown and quantified as described
(Ahmed et al., 1984).
Adoptive Transfer
Naive P14 T cells were isolated from spleen and lymph nodes by using a
CD8 isolation kit (Miltenyi) following the manufacturer’s instruction but
with the addition of biotin-aCD44 antibody during the biotin antibody
cocktail incubation step. The indicated number of naive P14 T cells was trans-
ferred intravenously into appropriate recipient mice. For the in vivo migration
assay, at indicated time after infection, 2–3 3 107 total lymphocytes from
pooled spleen and lymph nodes were transferred intravenously into sex-
matched recipient mice. In some experiments, cells were incubated with
500 mg blocking or control antibody in 300 ml PBS on ice for 1 hr and then
transferred into recipients without washing. Nineteen hours later, donor P14
T cells were quantified from the spleen and gut IEL compartment of the recip-
ient mice.
Purification of the IEL
For most experiments, the standard protocol was followed. Briefly, small
pieces of the small intestine were stirred at 800 rpm for 20 min in HBSS buffer
containing 1mM dithiothreitol and 10% FBS followed by a 15 s high speed
vortex. The released cells were purified by gradient centrifugation with 44%
and 67% Percoll. For the experiments shown in Figure 4, a more gentle isola-
tion stepwas performed before the standard vigorous step. Small pieces of the
small intestine were stirred at 400 rpm for 10min in HBSS buffer in the absence
of dithiothreitol. The vortex step was omitted for the gentle isolation. The
released cells from the gentle (loosely attached IEL) and the standard (tightly
attached IEL) steps were subjected to gradient centrifugation and FACS
analysis.
Antibodies and Flow Cytometry
Single-cell suspensions were prepared from the spleen, lymph nodes, and
small intestine after perfusion of the animal at the indicated time points after
infection. Cells were typically stained with antibodies specific for CD8,
CD103, CD90.1, CD69, CD49a (integrin a1), integrin b7, integrin a4b7, TCRb,
CD45.1, CD45.2, and PD-1 (eBioscience, Biolegend and BD) and TGF-bRII
(R&D Systems). For in vivo antibody blocking, anti-integrin a4 antibody
(CD49d, clone PS/2) was obtained from the UCSF monoclonal antibody
core. Anti-integrin a4b7 (clone DATK-32) was a generous gift from Dr. Eugene
Butcher. Cells were analyzed with a FACSCanto (BD) and analyzed with
FLOWJO (TreeStar) software.
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